Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ViaShield in Hemicraniectomies
NCT03371316Withdrawn
- Sponsor
- Globus Medical
- Start
- Jan 2018
- Primary completion
- Jan 2018
01
Overview
Open-label, single-arm trial in tissue adhesions, sponsored by Globus Medical. Primary endpoint: Adhesion at 8 months. Planned start Jan 2018; status: withdrawn.
02
Conditions
tissue adhesions
Beyond the preview
Go deeper on NCT03371316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371316.